Pharming Group N.V. (PHAR)
undefined
undefined%
At close: undefined
8.98
0.00%
After-hours Dec 13, 2024, 03:45 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Revenue 245.32M 205.62M 189.85M 228.39M 189.33M 154.58M 107.52M 16.69M 11.84M 25.76M 9.45M 14.04M 3.89M 762.07K 1.57M 924.35K 1.01M 194.01K 479.68K
Cost of Revenue 25.21M 17.56M 20.18M 25.34M 23.92M 25.37M 14.93M 4.93M 5.25M 4.17M 1.54M 5.64M 4.58M 121.03K - - 36.90M - 6.17M
Gross Profit 220.10M 188.06M 169.67M 203.06M 165.41M 129.20M 92.59M 11.77M 6.59M 21.60M 7.92M 8.39M -688.23K 641.04K 1.57M 924.35K -35.90M 194.01K -5.69M
Operating Income -4.88M 18.23M 27.84M 82.09M 68.23M 43.46M 26.29M -12.14M -14.03M 3.50M -9.54M -23.09M -23.98M -58.69M -39.90M -41.02M -35.90M -23.80M -21.84M
Interest Income 3.53M 85.00K 14.23M 769.95K 1.13M 20.59K 3.60K 5.26K 130.10K 218.88K - -4.54M -0.66 -792.66K 610.35K 2.81M 4.82M 2.91M 814.87K
Pretax Income -12.01M 14.99M 22.03M 47.47M 52.29M 980.32K -107.25M -18.44M -10.89M -7.01M -20.80M -31.86M -23.13M -80.65M -45.45M -36.48M -52.32M -24.48M -21.15M
Net Income -10.55M 13.67M 16.00M 37.75M 40.54M 28.59M -95.92M -18.44M -10.89M -7.01M -20.80M -31.86M -22.17M -74.97M -45.93M -36.48M -51.92M -24.41M -21.15M
Selling & General & Admin 87.50M 131.82M 92.05M 69.97M 65.90M 53.49M 44.86M 8.07M 5.28M 4.04M 3.48M 4.56M 4.23M 4.41M 5.11M 4.33M 4.12M 3.71M 2.73M
Research & Development 68.91M 52.53M 67.18M 41.46M 31.78M 33.04M 22.38M 16.18M 15.50M 14.18M 14.13M 25.59M 17.92M 28.14M 35.14M 29.03M 27.83M 11.10M 10.57M
Other Expenses 69.08M -14.52M -2.50M 9.54M -487.27K -684.00K -790.00K -335.00K -147.00K -105.00K -106.00K -2.06M 843.00K -15.17M 5.71M 8.07M -23.62M -1.64M 2.40M
Operating Expenses 225.49M 169.83M 156.72M 120.97M 97.19M 85.74M 66.30M 23.91M 20.62M 18.10M 17.46M 29.82M 23.25M 31.81M 41.18M 36.12M -440.32K 23.52M 16.15M
Interest Expense 5.96M 5.36M 5.92M 6.40M 13.35M 16.37M 21.28M 3.77M 135.57K 212.80K 3.29M 3.43M 276.07K 6.67M 11.87M 1.87M 1.94M 1.71M 10.66K
Selling & Marketing Expenses 6.82M 85.80M 56.75M 55.55M 44.71M 39.51M 37.70M 3.19M 1.19M - - - - - - - - - 2.73M
Cost & Expenses 250.70M 187.39M 176.91M 146.31M 121.11M 111.12M 81.23M 28.83M 25.87M 22.26M 19.00M 35.47M 27.82M 31.93M 41.18M 36.12M 36.46M 23.52M 22.32M
Income Tax -1.46M 1.31M 6.76M 6.83M 11.74M -27.61M -11.33M 3.77M 851.68K -6.08K 10.83M 6.31M -1.15M -5.69M 481.40K 4.07M -402.41K -67.31K 636.48K
Shares Outstanding (Basic) 657.03M 70.71M 70.12M 68.27M 67.35M 65.35M 50.04M 41.54M 40.87M 39.61M 21.46M 7.35M 4.74M 2.68M 1.17M 923.46K 915.95K 868.02K 797.91K
Shares Outstanding (Diluted) 657.02M 70.71M 70.12M 68.27M 67.35M 65.35M 50.04M 41.54M 40.87M 39.61M 21.46M 7.35M 4.74M 2.68M 1.17M 923.46K 915.95K 868.02K 797.91K
EPS (Basic) -0.01 0.21 0.25 0.58 0.65 0.44 -1.92 -0.44 -0.27 -0.18 -0.97 -4.33 -4.68 -27.94 -39.24 -39.5 -56.69 -28.12 -26.51
EPS (Diluted) -0.01 0.19 0.23 0.55 0.60 0.44 -1.92 -0.44 -0.27 -0.18 -0.97 -4.33 -4.68 -27.94 -39.24 -39.5 -56.69 -28.12 -26.51
EBITDA 9.88M 33.53M 48.78M 92.11M 71.46M 50.98M -39.81M -13.88M -14.75M 3.72M -15.83M -25.97M -24.13M -46.46M -33.29M -33.69M -47.90M -21.17M -19.86M
Depreciation & Amortization 15.93M 13.19M 19.61M 8.31M 5.80M 7.50M 4.10M 795.09K -716.11K 218.88K -6.29M -2.87M -155.53K 12.24M 6.60M 1.98M 2.05M 1.59M 1.23M